Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

1.

Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.

Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, Keppler OT, Zeuzem S, Sarrazin C, Lange CM.

Hepatology. 2013 Oct;58(4):1270-6. doi: 10.1002/hep.26488. Epub 2013 Aug 7.

PMID:
23703797
[PubMed - indexed for MEDLINE]
2.

Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.

Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R.

J Hepatol. 2007 Sep;47(3):366-72. Epub 2007 May 24.

PMID:
17561304
[PubMed - indexed for MEDLINE]
3.

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.

Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH.

Hepatology. 2012 Jan;55(1):68-76. doi: 10.1002/hep.24615.

PMID:
21858846
[PubMed - indexed for MEDLINE]
4.

Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy.

Su CW, Wu CY, Hung HH, Wu CH, Sheen IJ, Wu JC.

J Gastroenterol Hepatol. 2013 Dec;28(12):1849-58. doi: 10.1111/jgh.12283.

PMID:
23730852
[PubMed - indexed for MEDLINE]
5.

Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.

Terrier B, Carrat F, Geri G, Pol S, Piroth L, Halfon P, Poynard T, Souberbielle JC, Cacoub P.

J Hepatol. 2011 Oct;55(4):756-61. doi: 10.1016/j.jhep.2011.01.041. Epub 2011 Feb 18.

PMID:
21334402
[PubMed - indexed for MEDLINE]
6.

Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.

Huang YH, Hung HH, Chan CC, Lai CR, Chu CJ, Huo TI, Lee PC, Su CW, Lan KH, Huang HC, Lee IC, Lin HC, Lee SD.

Clin Vaccine Immunol. 2010 Jun;17(6):1048-53. doi: 10.1128/CVI.00460-09. Epub 2010 Apr 28.

PMID:
20427626
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.

Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA.

Hepatology. 2010 Jun;51(6):1933-44. doi: 10.1002/hep.23571.

PMID:
20512987
[PubMed - indexed for MEDLINE]
8.

The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.

Milosevic I, Delic D, Lazarevic I, Pavlovic IP, Korac M, Bojovic K, Jevtovic D.

J Clin Virol. 2013 Sep;58(1):54-8. doi: 10.1016/j.jcv.2013.06.017. Epub 2013 Jul 6.

PMID:
23838671
[PubMed - indexed for MEDLINE]
9.

Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.

Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, Syminelaki T, Papaioannou C, Nastos T, Karayiannis P.

J Hepatol. 2011 Jul;55(1):61-8. doi: 10.1016/j.jhep.2010.10.027. Epub 2010 Dec 5.

PMID:
21145875
[PubMed - indexed for MEDLINE]
10.

Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.

Shao J, Wei L, Wang H, Sun Y, Zhang LF, Li J, Dong JQ.

World J Gastroenterol. 2007 Apr 14;13(14):2104-7.

PMID:
17465456
[PubMed - indexed for MEDLINE]
Free Article
11.

[Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].

Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.

Zhonghua Gan Zang Bing Za Zhi. 2003 Mar;11(3):173-5. Chinese.

PMID:
12681068
[PubMed - indexed for MEDLINE]
12.

Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.

Chen J, Wang Z, Zhou B, Wang Y, Hou J.

Antivir Ther. 2012;17(1):71-9. doi: 10.3851/IMP1925.

PMID:
22267471
[PubMed - indexed for MEDLINE]
13.

Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.

Madan K, Batra Y, Jha JK, Kumar S, Kalra N, Paul SB, Singh R, Duttagupta S, Panda SK, Acharya SK.

Trop Gastroenterol. 2008 Apr-Jun;29(2):84-90.

PMID:
18972767
[PubMed - indexed for MEDLINE]
14.

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.

Sonneveld MJ, Rijckborst V, Cakaloglu Y, Simon K, Heathcote EJ, Tabak F, Mach T, Boucher CA, Hansen BE, Zeuzem S, Janssen HL.

Antivir Ther. 2012;17(1):9-17. doi: 10.3851/IMP1887.

PMID:
22267464
[PubMed - indexed for MEDLINE]
15.

Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.

You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Li YL, Lei H, Liu J, Chen HY, Tang BZ, Huang JH.

BMC Infect Dis. 2008 Sep 22;8:123. doi: 10.1186/1471-2334-8-123.

PMID:
18803883
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients.

Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM, Wang FS, Lau GK.

J Viral Hepat. 2009 Feb;16(2):104-12. doi: 10.1111/j.1365-2893.2008.01054.x. Epub 2008 Sep 26.

PMID:
19175882
[PubMed - indexed for MEDLINE]
17.

[Correlation of hepatocyte expression of hepatitis B viral core antigen and the clinicopathological characters in chronic hepatitis B patients].

Ding Y, Zou Z, Xu X, Zhao Z, Jia W, Fang Y, Li Y, Guo Y, Wang G.

Zhonghua Gan Zang Bing Za Zhi. 2014 Mar;22(3):185-9. doi: 10.3760/cma.j.issn.1007-3418.2014.03.008. Chinese.

PMID:
24824119
[PubMed - indexed for MEDLINE]
18.

Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir.

Leung N, Peng CY, Hann HW, Sollano J, Lao-Tan J, Hsu CW, Lesmana L, Yuen MF, Jeffers L, Sherman M, Min A, Mencarini K, Diva U, Cross A, Wilber R, Lopez-Talavera J.

Hepatology. 2009 Jan;49(1):72-9. doi: 10.1002/hep.22658.

PMID:
19065670
[PubMed - indexed for MEDLINE]
19.

Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia.

Al-Ashqar HI, Al-Quaiz M, Dahab ST, Peedikayil MC.

Ann Saudi Med. 2013 Mar-Apr;33(2):119-23. doi: 10.5144/0256-4947.2013.119.

PMID:
23951584
[PubMed - indexed for MEDLINE]
20.

Use of quantitative serum HBsAg for optimization of therapy in chronic hepatitis B patients treated with pegylated interferon alfa-2a: a Romanian cohort study.

Gheorghiţa VI, Caruntu FA, Curescu M, Olaru I, Radu MN, Colţan G, Streinu-Cercel A.

J Gastrointestin Liver Dis. 2013 Mar;22(1):27-32.

PMID:
23539387
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk